EphBs: An integral link between synaptic function and synaptopathies

Trends in Neurosciences

Volumn 35, Issue 5, 2012, Pages 293-304

  Sheffler Collins, Sean I ^a,b   Dalva, Matthew B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Ephrin; Neuropathic pain; NMDA receptors; Receptor tyrosine kinase; Synaptogenesis

Indexed keywords

EPHRIN RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN TYROSINE KINASE;

ALZHEIMER DISEASE; ANXIETY DISORDER; CELL STRUCTURE; HUMAN; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

ALZHEIMER DISEASE; ANIMALS; ANXIETY; BRAIN; HUMANS; NEURALGIA; NEUROGENESIS; RECEPTORS, EPH FAMILY; SYNAPSES;

EID: 84860388355     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2012.03.003     Document Type: Review

References (115)

1. Tallafuss A., et al. Organization of central synapses by adhesion molecules. Eur. J. Neurosci. 2010, 32:198-206.
2. Shen K., Cowan C.W. Guidance molecules in synapse formation and plasticity. Cold Spring Harb. Perspect. Biol. 2010, 2:a001842.
3. McMahon S.A., Diaz E. Mechanisms of excitatory synapse maturation by trans-synaptic organizing complexes. Curr. Opin. Neurobiol. 2011, 21:221-227.
4. Siddiqui T.J., Craig A.M. Synaptic organizing complexes. Curr. Opin. Neurobiol. 2010, 21:132-143.
5. Penzes P., et al. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 2011, 14:285-293.
6. Mabb A.M., et al. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 2011, 34:293-303.
7. van Spronsen M., Hoogenraad C.C. Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep. 2010, 10:207-214.
8. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
9. Sloniowski S., Ethell I.M. Looking forward to EphB signaling in synapses. Semin. Cell Dev. Biol. 2012, 23:75-82.
10. Kessels H.W., Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 2009, 61:340-350.
11. Lau C.G., Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 2007, 8:413-426.
12. Lu W., Roche K.W. Posttranslational regulation of AMPA receptor trafficking and function. Curr. Opin. Neurobiol. 2011, 10.1016/j.conb.2011.09.008.
13. Groc L.L., et al. Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives. Neuroscience 2009, 158:4-18.
14. Henley J.M., et al. Routes, destinations and delays: recent advances in AMPA receptor trafficking. Trends Neurosci. 2011, 34:258-268.
15. Yashiro K., Philpot B.D. Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticity. Neuropharmacology 2008, 55:1081-1094.
16. Kerchner G.A., Nicoll R.A. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat. Rev. Neurosci. 2008, 9:813-825.
17. Opazo P., Choquet D. A three-step model for the synaptic recruitment of AMPA receptors. Mol. Cell. Neurosci. 2010, 46:1-8.
18. Klein R. Bidirectional modulation of synaptic functions by Eph/ephrin signaling. Nat. Neurosci. 2009, 12:15-20.
19. Chen Y., et al. Eph receptors at synapses: implications in neurodegenerative diseases. Cell Signal. 2012, 24:606-611.
20. Lai K.O., Ip N.Y. Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr. Opin. Neurobiol. 2009, 19:275-283.
21. Egea J., Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol. 2007, 17:230-238.
22. Flanagan J.G., Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 1998, 21:309-345.
23. Himanen J.P., et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 2004, 7:501-509.
24. Pasquale E.B. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008, 133:38-52.
25. Genander M., Frisen J. Ephrins and Eph receptors in stem cells and cancer. Curr. Opin. Cell Biol. 2010, 22:611-616.
26. Papa M., et al. Morphological analysis of dendritic spine development in primary cultures of hippocampal neurons. J. Neurosci. 1995, 15:1-11.
27. Ziv N.E., Smith S.J. Evidence for a role of dendritic filopodia in synaptogenesis and spine formation. Neuron 1996, 17:91-102.
28. Kayser M.S., et al. EphB receptors couple dendritic filopodia motility to synapse formation. Neuron 2008, 59:56-69.
29. Stagi M., et al. SynCAM 1 participates in axo-dendritic contact assembly and shapes neuronal growth cones. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:7568-7573.
30. Chen S.X., et al. Neurexin-neuroligin cell adhesion complexes contribute to synaptotropic dendritogenesis via growth stabilization mechanisms in vivo. Neuron 2010, 67:967-983.
31. Kayser M.S., et al. Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J. Neurosci. 2006, 26:12152-12164.
32. McClelland A.C., et al. Ephrin-B1 and ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20487-120492.
33. Ethell I.M., et al. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 2001, 31:1001-1013.
34. Ko J., et al. Organization of the presynaptic active zone by ERC2/CAST1-dependent clustering of the tandem PDZ protein syntenin-1. J. Neurosci. 2006, 26:963-970.
35. Henkemeyer M., et al. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. J. Cell Biol. 2003, 163:1313-1326.
36. Cesa R., et al. Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. PLoS ONE 2011, 6:e19160.
37. Hendelman W.J., Aggerwal A.S. The Purkinje neuron: I. A Golgi study of its development in the mouse and in culture. J. Comp. Neurol. 1980, 193:1063-1079.
38. Henderson J.T., et al. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 2001, 32:1041-1056.
39. Liebl D.J., et al. mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system. J. Neurosci. Res. 2003, 71:7-22.
40. Kayser M.S., et al. Preferential control of basal dendritic protrusions by EphB2. PLoS ONE 2011, 6:e17417.
41. Shi Y., et al. Focal adhesion kinase acts downstream of EphB receptors to maintain mature dendritic spines by regulating cofilin activity. J. Neurosci. 2009, 29:8129-8142.
42. Simon A.M., et al. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. J. Alzheimers Dis. 2009, 17:773-786.
43. Penzes P., et al. Rapid induction of dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 2003, 37:263-274.
44. Tolias K.F., et al. The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron 2005, 45:525-538.
45. Tolias K.F., et al. The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7265-7270.
46. Irie F., Yamaguchi Y. EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP. Nat. Neurosci. 2002, 5:1117-1118.
47. Nishimura T., et al. Role of numb in dendritic spine development with a Cdc42 GEF intersectin and EphB2. Mol. Biol. Cell 2006, 17:1273-1285.
48. Margolis S.S., et al. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 2010, 143:442-455.
49. Yashiro K., et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 2009, 12:777-873.
50. Greer P.L., et al. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 2010, 140:704-716.
51. Buchert M., et al. The junction-associated protein AF-6 interacts and clusters with specific Eph receptor tyrosine kinases at specialized sites of cell-cell contact in the brain. J. Cell Biol. 1999, 144:361-371.
52. Bouvier D., et al. Pre-synaptic and post-synaptic localization of EphA4 and EphB2 in adult mouse forebrain. J. Neurochem. 2008, 106:682-695.
53. Nolt M.J., et al. EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner. J. Neurosci. 2011, 31:5353-5364.
54. Sahin M., et al. Eph-dependent tyrosine phosphorylation of ephexin1 modulates growth cone collapse. Neuron 2005, 46:191-204.
55. Andersson E.R. The role of endocytosis in activating and regulating signal transduction. Cell. Mol. Life Sci. 2011, 10.1007/s00018-011-0877-1.
56. Lin K.T., et al. Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J. Biol. Chem. 2008, 283:28969-28979.
57. Litterst C., et al. Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J. Biol. Chem. 2007, 282:16155-16163.
58. Marston D.J., et al. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat. Cell Biol. 2003, 5:879-888.
59. Cowan C.W., et al. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 2005, 46:205-217.
60. Zimmer M., et al. EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nat. Cell Biol. 2003, 5:869-878.
61. Pitulescu M.E., Adams R.H. Eph/ephrin molecules - a hub for signaling and endocytosis. Genes Dev. 2010, 24:2480-2492.
62. Fasen K., et al. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway. Traffic 2008, 9:251-266.
63. Contractor A., et al. Trans-synaptic Eph receptor-ephrin signaling in hippocampal mossy fiber LTP. Science 2002, 296:1864-1869.
64. Torres R., et al. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 1998, 21:1453-1463.
65. Calo L., et al. Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration. J. Neurochem. 2006, 98:1-10.
66. Hoogenraad C.C., et al. GRIP1 controls dendrite morphogenesis by regulating EphB receptor trafficking. Nat. Neurosci. 2005, 8:906-915.
67. Irie F., et al. EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1. Nat. Cell Biol. 2005, 7:501-509.
68. Dalva M.B., et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 2000, 103:945-956.
69. Grunwald I.C., et al. Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 2001, 32:1027-1040.
70. Slack S., et al. EphrinB2 induces tyrosine phosphorylation of NR2B via Src-family kinases during inflammatory hyperalgesia. Neuroscience 2008, 156:175-183.
71. Attwood B.K., et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety. Nature 2011, 473:372-375.
72. Takasu M.A., et al. Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. Science 2002, 295:491-495.
73. Chen B.S., Roche K.W. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368.
74. Liu Z., et al. EphB receptors co-distribute with a nicotinic receptor subtype and regulate nicotinic downstream signaling in neurons. Mol. Cell. Neurosci. 2008, 38:236-244.
75. Kuner R. Central mechanisms of pathological pain. Nat. Med. 2010, 16:1258-1266.
76. Song X.J., et al. Upregulation and redistribution of ephrinB and EphB receptor in dorsal root ganglion and spinal dorsal horn neurons after peripheral nerve injury and dorsal rhizotomy. Eur. J. Pain 2008, 12:1031-1039.
77. Song X.J., et al. EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats. Pain 2008, 139:168-180.
78. Kobayashi H., et al. Involvement of EphB1 receptor/EphrinB2 ligand in neuropathic pain. Spine 2007, 32:1592-1598.
79. Battaglia A.A., et al. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat. Neurosci. 2003, 6:339-340.
80. Conover J.C., et al. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat. Neurosci. 2000, 3:1091-1097.
81. Guo W., et al. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J. Neurosci. 2002, 22:6208-6217.
82. Han Y., et al. Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice. Mol. Pain 2008, 4:60.
83. Liu W.T., et al. An in vivo mouse model of long-term potentiation at synapses between primary afferent C=fibers and spinal dorsal horn neurons: essential role of EphB1 receptor. Mol. Pain 2009, 5:29.
84. Zhao J., et al. Nociceptor-expressed ephrin-B2 regulates inflammatory and neuropathic pain. Mol. Pain 2010, 6:77.
85. Liu S., et al. Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents. Cancer Res. 2011, 71:4392-4402.
86. Cao J.L., et al. Activation of peripheral ephrinBs/EphBs signaling induces hyperalgesia through a MAPKs-mediated mechanism in mice. Pain 2008, 139:617-631.
87. Ruan J.P., et al. EphrinBs/EphBs signaling is involved in modulation of spinal nociceptive processing through a mitogen-activated protein kinases-dependent mechanism. Anesthesiology 2010, 112:1234-1249.
88. Guan X.H., et al. Phosphatidylinositol 3-kinase mediates pain behaviors induced by activation of peripheral ephrinBs/EphBs signaling in mice. Pharmacol. Biochem. Behav. 2010, 95:315-324.
89. Dong Y., et al. Involvement of EphB1 receptor/ephrinB1 ligand in bone cancer pain. Neurosci. Lett. 2011, 496:163-167.
90. Orikawa Y., et al. Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 beta production in a cancer-induced pain model in mice. Mol. Pain 2010, 6:72.
91. Lupien S.J., et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10:434-445.
92. Barkus C., et al. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur. J. Pharmacol. 2010, 626:49-56.
93. Matys T., et al. Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16345-16350.
94. Pawlak D., et al. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J. Physiol. Pharmacol. 2003, 54:175-189.
95. Pawlak R., et al. Tissue plasminogen activator and plasminogen mediate stress-induced decline of neuronal and cognitive functions in the mouse hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18201-18206.
96. Lohman R.J., et al. A regulatory role for protease-activated receptor-2 in motivational learning in rats. Neurobiol. Learn. Mem. 2009, 92:301-309.
97. Chen Z.L., et al. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J. Neurosci. 1995, 15:5088-5097.
98. Izumi A., et al. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions. Neuropsychopharmacology 2008, 33:3237-3245.
99. Matsumoto-Miyai K., et al. NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin. J. Neurosci. 2003, 23:7727-7736.
100. Ishikawa Y., et al. Neuropsin (KLK8)-dependent and -independent synaptic tagging in the Schaffer-collateral pathway of mouse hippocampus. J. Neurosci. 2008, 28:843-849.
101. Tamura H., et al. Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo. J. Physiol. 2006, 570:541-551.
102. Xu J., et al. Peptide EphB2/CTF2 generated by the gamma-secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N-methyl-D-aspartate receptors. J. Biol. Chem. 2009, 284:27220-27228.
103. Walsh D.M., Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004, 44:181-193.
104. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
105. Ikonomovic M.D., et al. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Exp. Neurol. 1999, 160:194-204.
106. Sze C., et al. N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J. Neurol. Sci. 2001, 182:151-159.
107. Wilcox K.C., et al. Abeta oligomer-induced synapse degeneration in Alzheimer's disease. Cell. Mol. Neurobiol. 2011, 31:939-948.
108. Snyder E.M., et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
109. Cisse M., et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 2011, 469:47-52.
110. Moeller M.L., et al. EphB receptors regulate dendritic spine morphogenesis through the recruitment/phosphorylation of focal adhesion kinase and RhoA activation. J. Biol. Chem. 2006, 281:1587-1598.
111. Robbins E.M., et al. SynCAM 1 adhesion dynamically regulates synapse number and impacts plasticity and learning. Neuron 2010, 68:894-906.
112. Wang C.Y., et al. A novel family of adhesion-like molecules that interacts with the NMDA receptor. J. Neurosci. 2006, 26:2174-2183.
113. Ko J., et al. SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses. Neuron 2006, 50:233-245.
114. Varoqueaux F., et al. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
115. Sara Y., et al. Selective capability of SynCAM and neuroligin for functional synapse assembly. J. Neurosci. 2005, 25:260-270.